
Orlando Health Ventures led the $12M round for the resuscitation-device maker, joined by Hatteras Venture Partners and eight other investors.
410 Medical, a Durham-based medical device company focused on emergency and critical care resuscitation, closed a $12 million financing round. Orlando Health Ventures led the investment, joined by Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, Catalyst by Wellstar, Tampa General, and an undisclosed strategic investor.
The company's lead product, LifeFlow, received FDA clearance in 2016. It is designed to speed the delivery of fluid and blood products to patients with sepsis, hemorrhagic shock, and other life-threatening conditions. The new capital will support further development and commercialization of the platform.
410 Medical was founded in 2013 and has raised from a mix of health system venture arms and specialist healthcare funds. The round closed July 14.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.